Today: 21 May 2026
CBA stock holds near A$153 as CPI and RBA loom — what could move Commonwealth Bank shares next
11 January 2026
1 min read

CBA stock holds near A$153 as CPI and RBA loom — what could move Commonwealth Bank shares next

Sydney, Jan 11, 2026, 16:55 AEDT — Market closed

  • Commonwealth Bank shares ended Friday at A$153.22, slipping 0.08%
  • Attention now turns to late-January inflation figures and the RBA’s rate decision scheduled for early February
  • CBA will release its half-year results and announce an interim dividend on Feb. 11

Shares of Commonwealth Bank of Australia (CBA.AX) closed Friday at A$153.22, slipping 0.08%. Heading into Monday, focus is shifting away from company updates toward the latest signals on interest rates.

This matters since CBA trades like a rate-sensitive stock. Shifts in investor sentiment on interest rates can send bank shares up or down, even if the lender’s fundamentals stay the same.

The bank faces its next big milestone on Feb. 11, with half-year results and an interim dividend announcement lined up on its financial calendar. Shares will go ex-dividend on Feb. 18, meaning they’ll trade without entitlement to that payout.

CBA’s modest drop on Friday was notable amid wider sector losses. Westpac slid 0.29%, ANZ dropped 0.64%, and National Australia Bank edged down 0.19%.

The S&P/ASX 200 closed nearly unchanged on Friday. Energy shares climbed as oil prices bounced back, but investors held back ahead of a crucial U.S. jobs report and a Supreme Court decision linked to President Donald Trump’s trade war, an Australian Associated Press story in CommBank’s newsroom noted.

Australia’s next key data point arrives on Jan. 28 at 11:30 a.m. AEDT, when the Australian Bureau of Statistics releases its consumer price index for December. The CPI, a wide-ranging measure of inflation, plays a crucial role in shaping interest rate expectations.

The Reserve Bank of Australia will meet on Feb. 2–3, releasing its policy decision statement at 2:30 p.m. AEDT on Feb. 3. A media conference follows at 3:30 p.m.

RBA Deputy Governor Andrew Hauser told ABC last week that “Inflation above 3% — let’s be clear, it’s too high.” He noted the board will review the fourth-quarter CPI data set for release later this month. “Most of those numbers were broadly in line with our expectations,” Hauser said, according to the ABC report cited by Reuters. Reuters

For CBA, investors remain focused on the same model drivers: net interest margin (NIM) — the spread between loan earnings and deposit costs — and the containment of loan losses. In its latest quarterly update, the bank noted that competition and a lower cash rate squeezed margins. John Milroy, an adviser at Ord Minnett, added that “the stock continues to be expensive on any metric.” Reuters

The situation could shift quickly. A hotter inflation report or tougher talk from the RBA might send bond yields higher, putting pressure on rate-sensitive bank stocks. Meanwhile, any mortgage-related trouble would challenge the dividend narrative.

Stock Market Today

  • Sharda Cropchem Earnings Reveal Weak Cash Flow Despite Profit Growth
    May 20, 2026, 9:35 PM EDT. Sharda Cropchem Limited's (NSE:SHARDACROP) recent earnings report shows a statutory profit of ₹6.81 billion for the year ending March 2026, but free cash flow was significantly lower at ₹1.6 billion, resulting in a high accrual ratio of 0.23. This suggests the company's cash conversion is less than ideal, raising concerns about the sustainability of its earnings. Despite this, Sharda Cropchem's earnings per share (EPS) has grown impressively over the past three years. Investors remain cautious due to three warning signs surrounding the stock, with one marked as significant. The gap between profit and cash flow indicates that reported profits may overstate the company's underlying earning power.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week
Previous Story

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

BAT stock in focus: UBS sticks with Buy on British American Tobacco ahead of Feb results
Next Story

BAT stock in focus: UBS sticks with Buy on British American Tobacco ahead of Feb results

Go toTop